Health · 1 sources covering this

STAT+: Wagering on FDA changes, Regenxbio will submit Duchenne gene therapy for approval

Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to see another trial.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Wagering on FDA changes, Regenxbio will submit Duchenne gene therapy for approval
Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to see another trial.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/43326a99fbad28fe5fc7f368392292023426e35b"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Wagering on FDA changes, Regenxbio will submit Duchenne gene therapy for approval"></iframe>

STAT+: Wagering on FDA changes, Regenxbio will submit Duchenne gene therapy for approval

How 1 sources are covering this

STAT+: Wagering on FDA changes, Regenxbio will submit Duchenne gene therapy for approval

More from Health

STAT+: Pharmalittle: We’re reading about an FDA commissioner candidate, Germany’s plans for drug prices, and more

FDA finally analyzed its own youth tobacco data

STAT+: Ophthalmology venture grabs investors’ attention, raises $330 million

Why are crisis pregnancy centers saying they can 'rule out' ectopic pregnancy?

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Wagering on FDA changes, Regenxbio will submit Duchenne gene therapy for approval

More from Health

STAT+: Pharmalittle: We&#8217;re reading about an FDA commissioner candidate, Germany&#8217;s plans for drug prices, and more

FDA finally analyzed its own youth tobacco data

STAT+: Ophthalmology venture grabs investors’ attention, raises $330 million

Why are crisis pregnancy centers saying they can 'rule out' ectopic pregnancy?

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about an FDA commissioner candidate, Germany’s plans for drug prices, and more